Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer have?
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer has 75 citations in the OpenAlex counts ScholarIQ stores.
When was Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer published?
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer has 2011 year in the ScholarIQ index.
What is the open-access status of Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer?
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer has gold oa status in the ScholarIQ index.
What is the DOI of Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer?
The DOI for Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer is on the source record.
What is the PMID of Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer?
The PMID for Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer is on the source record.
What is the OpenAlex record for Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer?
The OpenAlex for Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer is on the source record.